News | August 23, 2023
Jupiter Life Line Hospitals raised Rs. 123 crore in pre IPO round
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Need to harmonize traditional and modern medicine to combat alarming health problems
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
The inspection was conducted from August 7 to August 11, 2023 and concluded without any observations.
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
Subscribe To Our Newsletter & Stay Updated
